IRIDEX Corporation (IRIX)

NCM – Real vaqt narxi. Valyuta: USD

1.13

-0.05 (-4.24%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

1.14

+0.01 (0.88%)

Bozordan keyin: Jun 26, 2026, 6:22 PM EDT

09.06.2026

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference.

25.05.2026

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.

19.05.2026

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

19.05.2026

Iridex Reports First Quarter 2026 Financial Results

MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the first quarter ended April 4, 2026.

05.05.2026

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the first quarter 2026 and provide a business update after the close of trading on May 19, 2026.

07.04.2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a new partnership with EyeProGPO, an ophthalmology-focused group purchasing organization serving ophthalmology practices, ambulatory surgery centers (ASC), and hospitals across the United States.

01.04.2026

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIX incurs narrower year-over-year loss per share in Q4 as growth in retina systems and glaucoma probes boosts revenues, though margins remain pressured by higher costs.

Videolar

No Data

There is no data to display

Press-relizlar

19.05.2026

Iridex Reports First Quarter 2026 Financial Results

07.04.2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

26.03.2026

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies

02.02.2026

Iridex Announces Plans to Relocate Headquarters

MOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced its intent to relocate the Company's headquarters from Mountain View, California to San Jose, California.

IRIDEX Corporation (IRIX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

IRIDEX Corporation (IRIX)

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Iridex Reports First Quarter 2026 Financial Results

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

Videolar

No Data

Press-relizlar

Iridex Reports First Quarter 2026 Financial Results

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Iridex Reports First Quarter 2026 Financial Results

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

Videolar

No Data

Press-relizlar

Iridex Reports First Quarter 2026 Financial Results

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Search stocks

IRIDEX Corporation (IRIX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

IRIDEX Corporation (IRIX)

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Iridex Reports First Quarter 2026 Financial Results

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

Videolar

No Data

Press-relizlar

Iridex Reports First Quarter 2026 Financial Results

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Iridex Reports First Quarter 2026 Financial Results

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

Videolar

No Data

Press-relizlar

Iridex Reports First Quarter 2026 Financial Results

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Announces Plans to Relocate Headquarters